Annual Drug Patent Expirations for ANDROGEL
Androgel is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. There are eleven patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for ANDROGEL.
This drug has thirty-five patent family members in twenty-nine countries.
The generic ingredient in ANDROGEL is testosterone. Two suppliers are listed for this compound. Additional details are available on the testosterone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com